Prediction of Failure to Retain Work 1 Year After Interdisciplinary Functional Restoration in Occupational Injuries

Brede, Emily; Mayer, Tom G.; Gatchel, Robert J.

doi:10.1016/j.apmr.2011.08.029

Cited by 20 publications

(7 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In each case, opioid treated workers were less likely to return to work than those who did not receive opioids. Opioid therapy retards return to work for injured workers in dose-dependent manner [11; 16; 29; 68; 71; 75]. It is important to be cautious in interpreting these non-randomized studies, because the patients who receive opioids are not the same patients as those who do not receive opioid.…”

Section: Opioid Efficacy For Chronic Non-cancer Pain: Short-term and mentioning

confidence: 99%

Opioid therapy for chronic pain in the United States: Promises and perils

Sullivan¹,

Howe²

2013

Pain

200

158

View full text Add to dashboard Cite

Opioid therapy offers the promise of reducing the burden of chronic pain in not just individual patients, but among the broad population of patients with chronic pain. Randomized trials have demonstrated that opioid therapy for up to 12–16 weeks is superior to placebo, but have not addressed longer term use. In the US, opioid sales have quadrupled during 2000–2010 with parallel increases in opioid accidental overdose deaths substance abuse admissions. Clinical use of long-term opioid therapy is characterized by a pattern of adverse selection, where high-risk patients are prescribed high-risk opioid regimens. This adverse selection may link these trends in use, abuse and overdose. Long-term opioid therapy appears to be associated with iatrogenic harm to the patients who receive the prescriptions and to the general population. The US has conducted an experiment of population-wide treatment of chronic pain with long-term opioid therapy. The benefits have been hard to demonstrate, but the harms are now well demonstrated.

show abstract

Section: Opioid Efficacy For Chronic Non-cancer Pain: Short-term and mentioning

confidence: 99%

Opioid therapy for chronic pain in the United States: Promises and perils

Sullivan¹,

Howe²

2013

Pain

200

158

View full text Add to dashboard Cite

show abstract

“…146 A study evaluating outcomes following occupational injury revealed that being given more than one opioid prescription or being given a course of opioids lasting more than 7 days is significantly associated with work disability at 1 year. 147 Although opioid use may be a marker of more severe injury, even after 1 year of interdisciplinary functional restoration, dependence on opioids is associated with an increased odds for failure to return to work (OR = 1.43; 95% CI:1.02 to 2.00) 102 and those reporting the highest opioid use are 11.6 times as likely to be receiving Social Security Disability Income/Supplemental Security Income compared with groups reporting no opioid use when they started the program. 148 …”

Section: Resultsmentioning

confidence: 99%

Characterizing the Interrelationships of Prescription Opioid and Benzodiazepine Drugs With Worker Health and Workplace Hazards

Kowalski-McGraw

Green-McKenzie

Pandalai

et al. 2017

Journal of Occupational &Amp; Environmental Medicine

View full text Add to dashboard Cite

Objective Prescription opioid and benzodiazepine drug use, which has risen significantly, can affect worker health. Exploration of the scientific literature assessed (1) interrelationships of such drug use, occupational risk factors, and illness and injury, and (2) occupational and personal risk factor combinations that can affect their use. Methods The scientific literature from 2000 to 2015 was searched to determine any interrelationships. Results Evidence for eight conceptual models emerged based on the search yield of 133 articles. These models summarize interrelationships among prescription opioid and benzodiazepine use with occupational injury and illness. Factors associated with the use of these drugs included fatigue, impaired cognition, falls, motor vehicle crashes, and the use of multiple providers. Conclusion Prescription opioid and benzodiazepine drugs may be both a personal risk factor for work-related injury and a consequence of workplace exposures.

show abstract

“…Although return to work refers only to the ability to initially obtain gainful employment, work retention indicates that individuals who have both obtained and maintained employment over the course of a year are not only vocationally recovered, but must have an adequate level of physical recovery and psychosocial functioning over an extended period of time. 52 In addition, the DYS profile group at FRP discharge was associated with increased rates of health care utilization from a new provider. Moreover, the DYS profile patients were more likely to have a new surgery to the original injury site at 1-year follow-up, compared with the AC or those with an Anomalous profile.…”

Section: Discussionmentioning

confidence: 98%